SEATTLE--(BUSINESS WIRE)--ZymoGenetics, Inc. (NASDAQ: ZGEN) today announced that it has filed a registration statement with the Securities and Exchange Commission (SEC). If and when the SEC declares the registration statement effective, it would allow the Company to offer and sell up to $100 million of its common stock, no par value per share, from time to time. The registration statement is intended to replace the Company’s previously filed shelf registration statement, which will expire on December 1, 2008.
